The Thornton Group

Call Us: (925)963-3258

The Endocrine Society today issued a Clinical Practice Guideline (CPG) advising against using testosterone therapy in healthy girls. Although the FDA approved testosterone therapy for the treatment of ailments involving the testes, pituitary and hypothalamus, it has not been approved for treating age-related decrease in testosterone levels. The U.S. National Institute on Aging is also anticipated to release the results of research on the safety of testosterone. The study involved nearly 800 elderly men with low testosterone and symptoms associated with this condition, for example http://tinyurl.com/guccrce physical and sexual dysfunction. Since the heart health of the men was monitored, the research is expected to shed more light on the safety of testosterone therapy.

The recent conflicting findings on testosterone therapy prompted Patel and his team to conduct a sizeable systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among men. An estimated 13 million men in the United States suffer from low testosterone, which occurs when the body doesn't make enough hormones as a result of a problem with the testicles or pituitary gland. This clarifies the sudden weight gain, obvious aging and loss of energy of a person.

No clear lower limit of testosterone was confirmed; however 15 ng per dL (0.5 nmol per L) generally is used. One study 38 found that women with 0 to 10 ng per dL (0 to 0.3 nmol per L) had markedly decreased sexual desire in all situations and absent or markedly reduced climaxes. As a result of studies like this, supplemented with anecdotal evidence, many girls are started on testosterone therapy. Most women can expect to spend one third of their lives in the postmenopausal stage. Depression, anger, moodiness, insomnia, and lack of well being are common criticisms of postmenopausal women.


What people are saying about the Thornton Group